BHASKAR DEWANGAN

Employment

Employment history is unavailable.

Education

• National Institute of Pharmaceutical Education and Research Ahmedabad PhD Research Scholar
  2020 - Present
• National Institute of Pharmaceutical Education and Research M. S. PHARM
  2018 - 2020

Projects & Funding

Projects & funding information is unavailable.

Publications (10)

• Synthesis and evaluation of HFIP bearing triazolo-amides as amyloid-β aggregation inhibitors and suppressors of aggregation induced neuroinflammation
  RSC Medicinal Chemistry 2026 DOI: 10.1039/D5MD00481K
  +Save
• ROS-responsive nucleobase conjugated chitosan: Synthesis and evaluations for biomedical applications
  Carbohydrate Polymers 2025 DOI: 10.1016/j.carbpol.2025.123353
  +Save
• Bifunctional backbone modified squaramide dipeptides as amyloid beta (Aβ) aggregation inhibitors
  Bioorganic and Medicinal Chemistry 2024 DOI: 10.1016/j.bmc.2023.117538
  +Save
• Metal Chelators as a Potential Therapeutic Agent for Alzheimer’s Disease
  Natural Product-based Synthetic Drug Molecules in Alzheimer's Disease 2023 DOI: 10.1007/978-981-99-6038-5_13
  +Save
• Alginate Based Hydrogel in Drug Delivery and Biomedical Applications
  Alginate Biomaterial 2023 DOI: 10.1007/978-981-19-6937-9_5
  +Save
• Alginate Based Hydrogel in Drug Delivery and Biomedical Applications
  Alginate Biomaterial: Drug Delivery Strategies and Biomedical Engineering 2023 DOI: 10.1007/978-981-19-6937-9_5
  +Save
• Microtubule stabilising peptides: new paradigm towards management of neuronal disorders
  RSC Medicinal Chemistry 2023 DOI: 10.1039/D3MD00012E
  +Save
• Design, synthesis and in-vitro evaluation of fluorinated triazoles as multi-target directed ligands for Alzheimer disease
  Bioorganic & Medicinal Chemistry Letters 2021 DOI: 10.1016/j.bmcl.2021.127999
  +Save
• Old Drugs with New Tricks: Paradigm in Drug Development Pipeline for Alzheimer’s Disease
  Central Nervous System Agents in Medicinal Chemistry 2021 DOI: 10.2174/1871524920666201021164805
  +Save
• Design and in-silico screening of Peptide Nucleic Acid (PNA) inspired novel pronucleotide scaffolds targeting COVID-19.
  Current computer-aided drug design 2020 DOI: 10.2174/1573409916666200923143935
  +Save